Balance Sheet - Amylyx Pharmaceuticals, Inc. (AMLX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 316.98 | 176.50 | 371.36 | 346.95 | 96.12 | 12.88 | 3.07 |
| Accounts receivable, net | 0.09 | 0.45 | 40.05 | 15.31 | 0.00 | ||
| Inventories | 0.00 | 38.32 | 9.77 | 0.00 | |||
| Other current assets | 6.60 | 12.48 | 14.93 | 10.11 | 8.83 | 0.76 | 0.14 |
| Total current assets | 323.67 | 189.43 | 464.67 | 382.13 | 104.95 | 13.64 | 3.20 |
| Total non-current assets | 8.97 | 4.20 | 52.79 | 9.32 | 0.66 | 0.47 | 0.02 |
| Total assets | 332.65 | 193.63 | 517.45 | 391.45 | 105.61 | 14.10 | 3.22 |
| Total current liabilities | 22.69 | 28.41 | 82.04 | 46.61 | 17.40 | 7.33 | 4.53 |
| Total non-current liabilities | 4.70 | 0.46 | 1.98 | 4.24 | 239.39 | 73.50 | 24.05 |
| Total liabilities | 27.39 | 28.87 | 84.02 | 50.85 | 256.78 | 80.83 | 28.58 |
| Total stockholders' equity | 305.26 | 164.77 | 433.43 | 340.61 | -151.17 | -66.73 | -25.36 |
| Common shares outstanding | 95 | 68 | 70 | 67 | 58 | 56 | 56 |
Show Quarterly Balance Sheet
Balance Sheet - Amylyx Pharmaceuticals, Inc. (AMLX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 279.77 | 316.98 | 343.99 | 180.83 | 204.07 | 176.50 | 234.40 | 309.81 | 373.29 | 371.36 | 355.05 | 357.28 | 345.67 | 346.95 | 162.59 | 206.68 | 255.21 | 96.12 | 125.70 | 0.00 | 12.88 | 12.88 |
| Accounts receivable, net | 0.09 | 0.23 | 0.20 | 0.30 | 0.45 | 1.73 | 4.09 | 20.35 | 40.05 | 29.35 | 33.47 | 17.56 | 15.31 | 0.14 | ||||||||
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 38.32 | 32.37 | 24.86 | 13.08 | 9.77 | 0.56 | ||||||||||||
| Other current assets | 5.26 | 6.60 | 9.16 | 5.86 | 11.78 | 12.48 | 9.14 | 12.82 | 16.89 | 14.93 | 17.34 | 11.79 | 12.75 | 10.11 | 8.91 | 9.46 | 10.28 | 8.83 | 4.24 | 0.76 | ||
| Total current assets | 285.02 | 323.67 | 353.38 | 186.89 | 216.14 | 189.43 | 245.26 | 326.72 | 410.53 | 464.67 | 434.11 | 427.39 | 389.05 | 382.13 | 172.20 | 216.14 | 265.49 | 104.95 | 129.94 | 12.88 | 13.64 | |
| Total non-current assets | 8.58 | 8.97 | 9.36 | 7.71 | 3.53 | 4.20 | 5.45 | 5.44 | 6.92 | 52.79 | 32.47 | 26.19 | 18.91 | 9.32 | 9.24 | 9.10 | 8.95 | 0.66 | 0.52 | -12.88 | 0.47 | |
| Total assets | 293.60 | 332.65 | 362.74 | 194.60 | 219.68 | 193.63 | 250.71 | 332.16 | 417.46 | 517.45 | 466.58 | 453.59 | 407.96 | 391.45 | 181.44 | 225.24 | 274.44 | 105.61 | 130.46 | 14.10 | ||
| Total current liabilities | 15.97 | 22.69 | 25.79 | 21.42 | 17.93 | 28.41 | 53.92 | 70.08 | 91.64 | 82.04 | 45.62 | 64.08 | 51.62 | 46.61 | 32.65 | 27.16 | 27.71 | 17.40 | 15.15 | 7.33 | ||
| Total non-current liabilities | 4.48 | 4.70 | 4.95 | 5.30 | 0.33 | 0.46 | 0.60 | 0.77 | 1.38 | 1.98 | 2.57 | 3.14 | 3.69 | 4.24 | 4.77 | 5.29 | 5.79 | 239.39 | 239.38 | 73.50 | ||
| Total liabilities | 20.44 | 27.39 | 30.75 | 26.72 | 18.26 | 28.87 | 54.51 | 70.85 | 93.02 | 84.02 | 48.18 | 67.22 | 55.31 | 50.85 | 37.42 | 32.45 | 33.49 | 256.78 | 254.53 | 80.83 | ||
| Total stockholders' equity | 273.16 | 305.26 | 332.00 | 167.88 | 201.42 | 164.77 | 196.20 | 261.31 | 324.44 | 433.43 | 418.40 | 386.37 | 352.65 | 340.61 | 144.03 | 192.79 | 240.95 | -151.17 | -124.07 | 5.34 | -66.73 | |
| Common shares outstanding | 111 | 95 | 93 | 89 | 86 | 69 | 68 | 68 | 68 | 69 | 70 | 70 | 71 | 65 | 59 | 58 | 52 | 55 | 55 | 46 | 46 | 46 |